NVAX · Novavax Inc · Documents

Jul 7

Current report 8-K Events of Jun 30

Entered into a material agreement

Jul 7

Proxy statement DEFA14A

Proxy statement

Jun 29

Proxy statement DEFA14A

Proxy statement

Jun 20

Proxy statement DEFA14A

Proxy statement

Jun 15

Proxy statement DEFA14A

Proxy statement

May 9

Earnings call

Q1 2023 earnings call

May 9

Current report 8-K

Financial results, Exit or restructuring costs, Regulation FD disclosure

May 9

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $80.95M ▼ 88.5% Net loss $293.91M Diluted EPS -$3.41

May 3

Proxy statement DEFR14A

Proxy statement

Apr 28

Proxy statement DEF 14A

Proxy statement

Apr 28

Annual report to holders ARS

Annual report to holders

Apr 28

Proxy statement DEFA14A

Proxy statement

Apr 18

Proxy statement PRE 14A

Proxy statement

Apr 4

Current report 8-K Events of Mar 30

Charter or bylaw amendment, or fiscal year change

Mar 22

Current report 8-K Events of Mar 20

Director or officer change, or executive pay

Mar 14

Current report 8-K

Regulation FD disclosure

Mar 2

Current report 8-K Events of Feb 28

Director or officer change, or executive pay

Feb 28

Earnings call

Q4 2022 earnings call

Feb 28

Current report 8-K

Financial results

Feb 28

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $1.98B ▲ 72.9% Net loss $657.94M Diluted EPS -$8.42

Feb 28

Registration statement S-3ASR

Registration statement

Jan 9

Current report 8-K Events of Jan 5

Director or officer change, or executive pay, Regulation FD disclosure

Dec 28

Current report 8-K Events of Dec 23

Entered into a material agreement, New debt or off-balance-sheet obligation, Unregistered sale of equity

Dec 21

Current report 8-K Events of Dec 20

Entered into a material agreement, New debt or off-balance-sheet obligation, Unregistered sale of equity

Dec 19

Current report 8-K Events of Dec 14

Entered into a material agreement, Other events

Dec 14

Current report 8-K

Regulation FD disclosure, Other events

Dec 9

Current report 8-K/A Events of Dec 8

Director or officer change, or executive pay

Nov 21

Current report 8-K Events of Nov 18

Ended a material agreement

Nov 9

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $734.58M ▲ 310.7% Net loss $168.61M

Nov 8

Earnings call

Q3 2022 earnings call

Nov 8

Current report 8-K

Financial results

Nov 1

Current report 8-K Events of Oct 29

Director or officer change, or executive pay

Oct 6

Current report 8-K Events of Sep 30

Entered into a material agreement

Aug 9

Earnings call

Q2 2022 earnings call

Aug 9

Current report 8-K Events of Aug 8

Financial results

Aug 9

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $185.93M ▼ 37.6% Net loss $510.49M

Jul 11

Current report 8-K Events of Jul 6

Entered into a material agreement

Jun 21

Current report 8-K Events of Jun 16

Director or officer change, or executive pay, Shareholder vote results

May 10

Earnings call

Q1 2022 earnings call

May 10

Current report 8-K Events of May 9

Financial results

May 10

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $703.97M ▲ 57.4% Net income $203.41M Diluted EPS $2.56

May 3

Proxy statement DEFA14A

Proxy statement

May 2

Proxy statement DEF 14A

Proxy statement

Apr 20

Current report 8-K

Regulation FD disclosure

Apr 20

Proxy statement PRE 14A Meeting Jun 16, 2022

Proxy statement

Mar 7

Current report 8-K Events of Mar 5

Director or officer change, or executive pay

Mar 1

Earnings call

Q4 2021 earnings call

Mar 1

Current report 8-K Events of Feb 28

Financial results

Mar 1

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $1.15B ▲ 141.0% Net loss $1.74B Diluted EPS -$23.44

Feb 10

Current report 8-K

Regulation FD disclosure